Network pharmacology and molecular docking-based investigations of Kochiae Fructus’s active phytomolecules, molecular targets, and pathways in treating COVID-19
COVID-19 disease is caused by SARS-CoV-2. Hyper-inflammation mediated by proinflammatory cytokines is humans’ primary etiology of SARS-CoV-2 infection. Kochiae Fructus is widely used in China as traditional Chinese medicine (TCM) to treat inflammatory diseases. Due to its anti-inflammatory propertie...
Main Authors: | Shakeel Ahmad Khan, Terence Kin Wah Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2022.972576/full |
Similar Items
-
Triterpenoids from Kochiae Fructus: Glucose Uptake in 3T3-L1 Adipocytes and <i>α-</i>Glucosidase Inhibition, In Silico Molecular Docking
by: Xue-Lin Chen, et al.
Published: (2023-01-01) -
Discovering Potential Anti-Oral Squamous Cell Carcinoma Mechanisms from Kochiae Fructus Using Network-Based Pharmacology Analysis and Experimental Validation
by: Youn-Sook Kim, et al.
Published: (2023-05-01) -
Investigations of nitazoxanide molecular targets and pathways for the treatment of hepatocellular carcinoma using network pharmacology and molecular docking
by: Shakeel Ahmad Khan, et al.
Published: (2022-07-01) -
Predicting Potential Molecular Mechanisms of Crataegi Fructus in the Treatment of Coronary Heart Disease Based on Network Pharmacology and Molecular Docking Technology
by: YANG Min, et al.
Published: (2022-11-01) -
Exploring the Mechanism of Hippophae Fructus Anti-obesity through Network Pharmacology and Molecular Docking
by: Mengke LU, et al.
Published: (2024-03-01)